The Autoridade Nacional Reguladora de Medicamentos (ANARME) participated in the Zazibona Product Evaluation Quality Circle held in Johannesburg, South Africa, on 5 and 6 November 2026.
Nazália Macuvele, Director of the Division of Evaluation of Medicines, Biological Products and Health at ANARME, represented the authority. She was joined by representatives from Mozambican pharmaceutical companies Mozpharma, ACE Healthcare, Eurofarma and Sociedade Moçambicana de Medicamentos.
The meeting brought together regulatory authorities and pharmaceutical industry participants from across the Southern African Development Community (SADC). Its purpose was to strengthen collaboration and harmonise processes for evaluating and registering medicines in the region.
The agenda focused on sharing knowledge and experiences between regulators and industry, with emphasis on improving product evaluation processes, ensuring medicine quality, safety and efficacy, and promoting timely access to medicines across SADC member states.
The Zazibona initiative operates as a collaborative mechanism for joint assessment of medicine dossiers among participating national regulatory authorities. Quality circles provide structured forums for technical discussion and alignment of regulatory standards.
Source: Autoridade Nacional Reguladora de Medicamentos (ANARME), news release, 9 November 2026: https://anarme.gov.mz/mocambique-participa-no-ciclo-de-qualidade-zazibona-na-africa-do-sul/
